Infection Control Accreditation Program (ICAP): Distribution partner signs key MoU for MENA region

Dr. Brill signed a Memorandum of Understanding (MoU) with Thumbay Marketing & Distribution Company (TMDC), the marketing and distribution company owned and operated by Thumbay Group. According to the MoU, TMDC will represent Dr. Brill´s Infection Control Accreditation Program (ICAP) in the MENA region. The MoU was signed by Mr. Akbar Moideen Thumbay, Vice President of the Healthcare Division of Thumbay Group, on behalf of TMDC and Dr. Florian H. H. Brill. The MoU was signed in the presence of H.E. Elke Badde - Undersecretary of Health and Consumer Protection of the Free and Hanseatic City of Hamburg, Dr. Hans-Joerg Schmidt Trenz - CEO of Hamburg Chamber of Commerce as well as representatives of healthcare companies and service providers from Hamburg. Mr. Akbar Moideen Thumbay said, "TMDC is happy to represent Dr. Brill's ICAP program in the MENA region. We are glad that H.E. Elke Badde was here to witness this landmark partnership. We hope that this new association would embark on many more mutually beneficial ventures, in the future." H.E. Elke Badde and Prof. Dr. Hans-Joerg Schmidt Trenz, in their greeting remarks assured their continuous support for the new cooperation between Thumbay Group and Dr. Brill Group.

About Thumbay Group

Thumbay Group is an international business conglomerate headquartered in DIFC - Dubai. The Group has successfully diversified into 13 different sectors in a span of just 17 years. The Group today employs more than 3000 people, which will rise to 6000 with the completion of ongoing projects in the next two years, and to 15,000 employees by the end of 2020. The Gulf Medical University, the leading private medical university in the region owned and operated by Thumbay Group has a student cohort of over 73 nationalities and faculty and staff from over 22 countries. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University, is one of the largest healthcare services provider in the UAE, serving over 2500 patients daily, from more than 175 countries. Apart from being an acknowledged leader in the health sector, Thumbay Group operates a reputed pharmacy chain, diagnostic centres, multi-brand retail outlets, world-class wellness centres, a prestigious chain of coffee shops, restaurants, popular health & lifestyle publication, etc. Source: www.brillhygiene.com 

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …